隐匿性高血压：一种常见但隐匿的高血压表现形式。
Masked hypertension: a common but insidious presentation of hypertension.
作者信息
McKay D W, Myers Martin G, Bolli Peter, Chockalingam Arun
机构信息
Division of Basic Medical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
出版信息
Can J Cardiol. 2006 May 15;22(7):617-20. doi: 10.1016/s0828-282x(06)70285-9.
Abstract
A patient has masked hypertension when his office blood pressure is less than 140/90 mmHg but his ambulatory or home blood pressure readings are in the hypertensive range. Several recent studies have demonstrated that cardiovascular risk is similar between those with masked hypertension and those with sustained hypertension. The prevalence of masked hypertension in Canada is not known, but data from other countries suggest rates greater than 8%. Physicians need to use careful clinical judgment to identify and treat subjects with masked hypertension. The present review discusses masked hypertension, its importance to clinical practice and some aspects of patient management.
摘要
当患者诊室血压低于140/90 mmHg，但动态血压或家庭血压读数处于高血压范围时，该患者即患有隐匿性高血压。最近的几项研究表明，隐匿性高血压患者与持续性高血压患者的心血管风险相似。加拿大隐匿性高血压的患病率尚不清楚，但其他国家的数据显示该患病率超过8%。医生需要运用审慎的临床判断来识别和治疗隐匿性高血压患者。本综述讨论了隐匿性高血压、其在临床实践中的重要性以及患者管理的一些方面。
相似文献
1
Masked hypertension: a common but insidious presentation of hypertension.隐匿性高血压：一种常见但隐匿的高血压表现形式。
Can J Cardiol. 2006 May 15;22(7):617-20. doi: 10.1016/s0828-282x(06)70285-9.
2
Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement.基于诊室、家庭和动态血压测量对患者进行分类的策略。
Hypertension. 2015 Jun;65(6):1258-65. doi: 10.1161/HYPERTENSIONAHA.114.05038. Epub 2015 Apr 13.
3
Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).高血压患者的血压控制、心血管风险状况及隐匿性未控制高血压（MUCH）的患病率
Med Arch. 2016 Jul 27;70(4):274-279. doi: 10.5455/medarh.2016.70.274-279.
4
Masked hypertension: how can the condition be detected?隐匿性高血压：如何检测这种病症？
Blood Press Monit. 2004 Dec;9(6):297-9. doi: 10.1097/00126097-200412000-00005.
5
[2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].[2013年动态血压监测在成人高血压诊断、心血管及其他高血压相关风险评估以及治疗目标达成方面的建议（摘要）。国际时间生物学学会（ISC）、美国医学时间生物学与时间治疗学协会（AAMCC）、西班牙应用时间生物学、时间治疗学与血管风险学会（SECAC）、西班牙动脉粥样硬化学会（SEA）以及罗马尼亚内科医学学会（RSIM）联合推荐]
Clin Investig Arterioscler. 2013 Apr-Jun;25(2):74-82. doi: 10.1016/j.arteri.2013.03.002. Epub 2013 Apr 30.
6
Masked hypertension: a review.隐匿性高血压：综述
Hypertens Res. 2007 Jun;30(6):479-88. doi: 10.1291/hypres.30.479.
7
Evaluation of prehypertension and masked hypertension rate among clinically normotensive patients.评估临床血压正常患者的高血压前期和隐匿性高血压发生率。
Clin Exp Hypertens. 2016;38(2):218-24. doi: 10.3109/10641963.2015.1047951. Epub 2016 Jan 28.
8
Prevalence of Masked Hypertension in Subjects Treated with Antihypertensive Drugs as Assessed by Morning versus Evening Home Blood Pressure Measurements: the J-HOME study.通过早晚家庭血压测量评估接受抗高血压药物治疗的受试者中隐匿性高血压的患病率：J-HOME研究
Clin Exp Hypertens. 2008 Apr;30(3):277-87. doi: 10.1080/10641960802071018.
9
Ambulatory blood pressure monitoring: is it mandatory for blood pressure control in treated hypertensive patients?: prospective observational study.动态血压监测：对于接受治疗的高血压患者的血压控制是否必不可少？前瞻性观察性研究。
Int J Cardiol. 2013 Oct 3;168(3):2255-63. doi: 10.1016/j.ijcard.2013.01.209. Epub 2013 Mar 7.
10
Determinants of masked hypertension in the general population: the Finn-Home study.一般人群中隐匿性高血压的决定因素：芬兰家庭研究。
J Hypertens. 2011 Oct;29(10):1880-8. doi: 10.1097/HJH.0b013e32834a98ba.
引用本文的文献
1
Masked hypertension and its associated cardiovascular risk in young individuals: the African-PREDICT study.年轻人中的隐匿性高血压及其相关心血管风险：非洲PREDICT研究
Hypertens Res. 2016 Mar;39(3):158-65. doi: 10.1038/hr.2015.123. Epub 2015 Nov 26.
2
Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levels.掩蔽性高血压与动脉粥样硬化形成：血管紧张素原和松弛素血浆水平的影响。
J Clin Hypertens (Greenwich). 2013 May;15(5):333-6. doi: 10.1111/jch.12075. Epub 2013 Feb 12.
3
Masked hypertension and atherogenesis: the impact on adiponectin and resistin plasma levels.隐匿性高血压与动脉粥样硬化形成：对脂联素和抵抗素血浆水平的影响。
J Clin Hypertens (Greenwich). 2009 Feb;11(2):61-5. doi: 10.1111/j.1751-7176.2008.00070.x.
4
Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association.关于家庭血压监测的使用与报销的行动呼吁：美国心脏协会、美国高血压学会和预防心血管护士协会的联合科学声明
Hypertension. 2008 Jul;52(1):10-29. doi: 10.1161/HYPERTENSIONAHA.107.189010. Epub 2008 May 22.
5
Masked hypertension definition, impact, outcomes: a critical review.隐匿性高血压的定义、影响及转归：一项批判性综述
J Clin Hypertens (Greenwich). 2007 Dec;9(12):956-63. doi: 10.1111/j.1524-6175.2007.07418.x.
6
Practical advice for home blood pressure measurement.家庭血压测量的实用建议。
Can J Cardiol. 2007 May 15;23(7):577-80. doi: 10.1016/s0828-282x(07)70804-8.
本文引用的文献
1
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.2006年加拿大高血压教育计划高血压管理建议：第一部分——血压测量、诊断及风险评估
Can J Cardiol. 2006 May 15;22(7):573-81. doi: 10.1016/s0828-282x(06)70279-3.
2
Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study.根据早晚家庭血压值的平均值定义的隐匿性未控制和治疗的白大衣高血压患病率：来自日本家庭与办公室测量评估研究。
Blood Press Monit. 2005 Dec;10(6):311-6. doi: 10.1097/00126097-200512000-00005.
3
Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension.接受治疗的反应性、隐匿性、假性抵抗性和真性抵抗性高血压患者的心血管结局
Am J Hypertens. 2005 Nov;18(11):1422-8. doi: 10.1016/j.amjhyper.2005.05.014.
4
Extending the reach of ambulatory blood pressure monitoring: masked and resistant hypertension.
Am J Hypertens. 2005 Nov;18(11):1385-7. doi: 10.1016/j.amjhyper.2005.05.029.
5
[Is masked hypertension an artefact due to the blood pressure measurement method and threshold effects?].隐匿性高血压是否是由于血压测量方法和阈值效应导致的假象？
Arch Mal Coeur Vaiss. 2005 Jul-Aug;98(7-8):751-6.
6
Isolated home hypertension in the morning is associated with target organ damage in patients with type 2 diabetes.
J Atheroscler Thromb. 2005;12(4):225-31. doi: 10.5551/jat.12.225.
7
Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME study.来自J-HOME研究的接受治疗的高血压患者在家中和办公室出现的孤立性未控制高血压。
J Hypertens. 2005 Sep;23(9):1653-60. doi: 10.1097/01.hjh.0000178334.33352.56.
8
Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.通过24小时动态血压监测检测出的“隐匿性”高血压和“白大褂”高血压的预后：大岛研究的10年随访
J Am Coll Cardiol. 2005 Aug 2;46(3):508-15. doi: 10.1016/j.jacc.2005.03.070.
9
White-coat and masked hypertension in children: association with target-organ damage.儿童白大衣高血压和隐匿性高血压：与靶器官损害的关联
Pediatr Nephrol. 2005 Aug;20(8):1151-5. doi: 10.1007/s00467-005-1979-5. Epub 2005 Jun 10.
10
Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon?通过动态血压与家庭血压监测评估的隐匿性高血压：是同一现象吗？
Am J Hypertens. 2005 Jun;18(6):772-8. doi: 10.1016/j.amjhyper.2005.01.003.
Zotero 插件